Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual

This publication has 11 references indexed in Scilit:

• Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
  New England Journal of Medicine, 2016
• A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners
  Journal of Substance Abuse Treatment, 2015
• Extended-release naltrexone for alcohol and opioid dependence: A meta-analysis of healthcare utilization studies
  Journal of Substance Abuse Treatment, 2014
• Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions
  Substance Abuse, 2012
• Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
  The Lancet, 2011
• Concerns about injectable naltrexone for opioid dependence
  The Lancet, 2011
• Heroin-Dependent Inmates' Experiences with Buprenorphine or Methadone Maintenance
  Journal of Psychoactive Drugs, 2010
• Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence
  Archives of General Psychiatry, 2006
• Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
  Drug and Alcohol Dependence, 2005
• Medical and Psychiatric Conditions of Alcohol and Drug Treatment Patients in an HMO
  Archives of internal medicine (1960), 2003